Girish Kulle Resident, Department of Emergency Medicine, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India
Anita Rawat Principal Consultant, Emergency Medicine, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India
Kishalay Datta HOD and Director, Emergency Medicine, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India
Goonja Bhattachary Resident, Department of Emergency Medicine, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India
Address for correspondence: Girish Kulle, Resident, Department of Emergency Medicine, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India E-mail: gkulle108@gmail.com
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Girish Kulle, Anita Rawat, Kishalay Datta et. al, When Immunity, Coagulopathy, and Kidneys Collide: A Rare Case of Spontaneous SAH. Ind J Emerg Med. 2026; 12(2): 71-73.
Timeline
Received : February 04, 2026
Accepted : March 05, 2026
Published : June 30, 2026
Abstract
Subarachnoid haemorrhage (SAH) is a life-threatening neurological emergency, most often caused by aneurysmal rupture. However, in patients with multiple systemic comorbidities, including autoimmune disease, coagulopathy, and endstage renal disease, the presentation and outcome may be particularly devastating. We report the case of a 56-year-old male with a background of lupus nephritis, secondary antiphospholipid antibody syndrome, chronic kidney disease on
dialysis, and prior cerebrovascular accident who presented with acute headache and subsequently developed spontaneous SAH. Despite timely diagnosis and supportive management, the patient’s condition rapidly deteriorated and
he succumbed. This case underscores the multifactorial risks of intracranial haemorrhage in complex autoimmune and renal disease patients, and emphasizes the need for vigilant monitoring and individualized risk-benefit decisions regarding antithrombotic therapy.
References
1. Kamel H., Navi B.B., Sriram N., Hovsepian D.A., Devereux R.B., Elkind M.S. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014; 370(14): 1307–1315.
2. Sultan S.M., Begum S., Isenberg D.A. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus and intracranial haemorrhage. Ann Rheum Dis. 2003; 62(4): 362–365.
3. Toyoda K., Fujii K., Fujimi S., Kumai Y., Tsuchimochi H., Ibayashi S., Iida M. Stroke in patients on maintenance hemodialysis: A 22- year single-center study. Am J Kidney Dis. 2005; 45(6): 1058–1066.
4. Sood M.M., Larkina M., Thumma J.R., Tentori F., Bieber B.A., Gillespie B.W., et al. Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: Results from the DOPPS. Kidney Int. 2013; 84(3): 600–608.
5. Razvi S.S., Weaver J.U., Markey J., Grundy D., Hall R. Subarachnoid haemorrhage in systemic lupus erythematosus: Case Report and literature review. Clin Neurol Neurosurg. 1995; 97(3): 235–238.
6. Baizabal-Carvallo J.F., Barragán-Campos H.M., Padilla-Aranda H., Alonso-Juárez M., Estanol B., Cantu C. Intracerebral hemorrhage in patients with systemic lupus erythematosus. Eur J Neurol. 2007; 14(4): 373–379.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Girish Kulle, Anita Rawat, Kishalay Datta et. al, When Immunity, Coagulopathy, and Kidneys Collide: A Rare Case of Spontaneous SAH. Ind J Emerg Med. 2026; 12(2): 71-73.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.